-
Mashup Score: 0Future of targeted therapies for non-colorectal GI cancers - 1 year(s) ago
Teresa Macarulla, MD, PhD, Vall d’Hebron University Hospital, Barcelona, Spain, discusses promising targeted therapies for non-colorectal gastrointestinal cancers, including HER2-targeted…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Annalisa Trama, MD, PhD, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, compares the prognosis of patients with head and…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 Annalisa Trama of @IstTumori talks on survival differences in head and neck cancer between Asia and Europe Watch: 👉https://t.co/ftkXJHEyKF👈 #ESMOAsia22 @myESMO
-
-
Mashup Score: 1EXTREME regimen vs. cetuximab + cisplatin + paclitaxel for recurrent/metastatic head and neck cancer - 1 year(s) ago
Avinash Khadela, PhD, L.M. College Of Pharmacy, Ahmedabad, India, explains a study comparing the EXTREME regimen to a paclitaxel-based regimen…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 @AvinashKhadela of L.M. College Of Pharmacy talks on the EXTREME regimen vs. cetuximab + cisplatin + paclitaxel for recurrent/metastatic head and neck cancer Watch: 👉https://t.co/AJiWfbgqQ7👈 #ESMOAsia22 @myESMO
-
-
Mashup Score: 0
Tomohiro Matsuda, PhD, National Cancer Center, Tokyo, Japan, discusses the challenges of sharing patient data between healthcare systems in Asian…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 Tomohiro Matsuda of National Cancer Center, Japan, discusses the challenges of data sharing between healthcare systems in Asian countries Watch: 👉https://t.co/MmPkOyM1C5👈 #ESMOAsia22 @myESMO
-
-
Mashup Score: 1Clinical trials investigating immunotherapy for gastric cancer - 1 year(s) ago
Kohei Shitara, MD, National Cancer Center Hospital East, Chiba, Japan, talks on how to improve outcomes for patients with gastric…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 @KoheiShitara of National Cancer Center Hospital East, Japan, talks on clinical trials investigating immunotherapy for gastric cancer Watch: 👉https://t.co/vsiAfmsjJd👈 #ESMOAsia22 @myESMO #STCsm #GastricCancer
-
-
Mashup Score: 0Optimizing genomic testing for non-colorectal GI cancers - 1 year(s) ago
Teresa Macarulla, MD, PhD, Vall d’Hebron University Hospital, Barcelona, Spain, talks on how we can optimize genomic testing in non-colorectal…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 @MacarullaTeresa of @VHIO talks on optimizing genomic testing for non-colorectal GI cancers Watch: 👉https://t.co/LWdBOJ86ZH👈 #ESMOAsia22 @myESMO
-
-
Mashup Score: 0The EXTREME regimen for head and neck cancer - 1 year(s) ago
Avinash Khadela, PhD, L.M. College Of Pharmacy, Ahmedabad, India, explains the EXTREME regimen of cetuximab, cisplatin, and 5-fluorouracil and its…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 @AvinashKhadela of L.M. College Of Pharmacy explains the EXTREME regimen for head and neck cancer Watch: 👉https://t.co/BmYFdvEHlV👈 #ESMOAsia22 @myESMO
-
-
Mashup Score: 0RARECAREnet-Asia: Epidemiology of rare cancers in Asia - 1 year(s) ago
Annalisa Trama, MD, PhD, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, explains the RARECAREnet-Asia collaboration, which aims to collect…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 Annalisa Trama of @IstTumori talks on RARECAREnet-Asia: Epidemiology of rare cancers in Asia Watch: 👉https://t.co/1xlCuZW8n3👈 #ESMOAsia22 @myESMO
-
-
Mashup Score: 0Updates from ESMO Asia 2022 - 1 year(s) ago
The ESMO Asia 2022 congress took place on the 2nd to the 4th of December in Singapore. We heard from…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🔈Check out our latest podcast, covering some of our highlights from #ESMOAsia22!! Listen here: 🎧 https://t.co/khArDff6F9 🎧 And don't forget to take a look at the rest of our interviews over on https://t.co/ys1d8pDAKO!! 💻 @myESMO
-
-
Mashup Score: 0Unmet needs in chemoradiotherapy for esophageal cancer - 1 year(s) ago
Ken Kato, MD, PhD, National Cancer Center Hospital, Tokyo, Japan, discusses the unmet needs in chemoradiotherapy for locally advanced esophageal…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 Ken Kato (@KEN_K_) of National Cancer Center Hospital, Japan, discusses unmet needs in chemoradiotherapy for esophageal cancer Watch: 👉https://t.co/jIeQAHjCxX👈 #ESMOAsia22 @myESMO #ESOCsm
-
🎥 @MacarullaTeresa of @VHIO talks on the future of targeted therapies for non-colorectal GI cancers Watch: 👉https://t.co/hiwwYW6erN👈 #ESMOAsia22 @myESMO